Health TrialsbyHealthPanel

Biobeat Digital Home Monitoring Feasibility

ConditionsThoracic SurgeryHome Monitoring
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

To assess the feasibility of evaluating postoperative home monitoring with Biobeat digital monitoring. The investigators hypothesize that the Biobeat digital home monitoring platform will lead to a decrease in unplanned visits to the ED (Emergency Department). In addition, patients' quality of life is postulated to be improved compared to patients receiving the current standard of care without home monitoring.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient willing to provide informed consent

Wi-fi or cellular connectivity at the patient's home

Patient undergoing elective lung cancer surgery

Patient familiar/comfortable with the use of technology such as online banking.

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Digital Group

    Other intervention

    Once patients are ready for discharge, patients in the digital group will be sent home with the Biobeat digital monitoring kit with written \& oral instructions on how it will be used in maintaining continuity of care which will track ECG (electrocardiogram), HR, NIBP, SPO2, and pain scores. A continuous recording and two-lead ECG patch will be applied and activated at the time of discharge to identify any paroxysmal atrial fibrillation.

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Control GroupNo intervention 0 interventions
Group B: Digital GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

To assess whether conducting a larger randomized trial of digital home monitoring vs. standard of care is feasible in terms of recruitment, data collection and logistics.

The trial will be deemed feasible if \>/= 60% of eligible patients are recruited, \>/= 80% of data is collected, and \</= 20% of patients are lost to follow-up.

Time frame
365 days

Secondary outcomes

1

Number of ED Visits

Number of ED visits

Time frame
30 days from discharge
2

Readmission Rates

Number of readmissions

Time frame
30 days from discharge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead sponsor

London Health Sciences Centre

Sponsor institution

Source ClinicalTrials.gov
Apply now